VETTRAINO, MARINA ELEONORA
 Distribuzione geografica
Continente #
NA - Nord America 714
EU - Europa 410
AS - Asia 87
AF - Africa 50
OC - Oceania 1
SA - Sud America 1
Totale 1.263
Nazione #
US - Stati Uniti d'America 713
GB - Regno Unito 129
IT - Italia 62
CN - Cina 55
DE - Germania 46
SE - Svezia 43
UA - Ucraina 33
IN - India 25
IE - Irlanda 21
TG - Togo 20
CH - Svizzera 19
RU - Federazione Russa 13
FR - Francia 12
BG - Bulgaria 11
ZA - Sudafrica 10
CI - Costa d'Avorio 9
EE - Estonia 9
NG - Nigeria 8
BE - Belgio 7
SC - Seychelles 3
JO - Giordania 2
NL - Olanda 2
AU - Australia 1
BR - Brasile 1
CZ - Repubblica Ceca 1
ES - Italia 1
FI - Finlandia 1
IL - Israele 1
LB - Libano 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SG - Singapore 1
TR - Turchia 1
Totale 1.263
Città #
Southend 115
Chandler 101
Fairfield 101
Ashburn 75
Woodbridge 54
Wilmington 49
Seattle 43
Ann Arbor 36
Houston 32
Cambridge 30
Bologna 29
Princeton 26
Dublin 21
Jacksonville 20
Lomé 20
Bern 19
New York 17
Padova 11
Sofia 11
Westminster 11
Nanjing 10
Abidjan 9
Shenyang 9
Abeokuta 8
Jinan 8
Brussels 7
Berlin 6
Falls Church 6
Mülheim 5
San Diego 5
Beijing 4
Los Angeles 4
Redmond 4
Haikou 3
Mahé 3
Saint Petersburg 3
San Venanzo 3
Taiyuan 3
Tianjin 3
Amman 2
Amsterdam 2
Bühl 2
Changsha 2
Des Moines 2
Hebei 2
Jiaxing 2
Milan 2
Nanchang 2
Olalla 2
Pont-Canavese 2
Turin 2
Azor 1
Boardman 1
Costa Mesa 1
Dallas 1
Dearborn 1
Edinburgh 1
Florence 1
Fuzhou 1
Guangzhou 1
Hefei 1
Helsinki 1
Istanbul 1
Kemerovo 1
Kuban 1
Kunming 1
Las Vegas 1
London 1
Madrid 1
New Bedfont 1
Norwalk 1
Pasadena 1
Phoenix 1
Pune 1
Quzhou 1
Riyadh 1
San Juan 1
São Paulo 1
Tallinn 1
Taranto 1
Verona 1
Washington 1
Zhengzhou 1
Totale 980
Nome #
Inhibition of lactic dehydrogenase as a way to increase the anti-proliferative effect of multi-targeted kinase inhibitors. 151
Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinoma cell lines. 139
Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways. 127
Galloflavin (CAS 568-80-9), a novel inhibitor of lactate dehydrogenase. 125
Effect of sorafenib on the energy metabolism of hepatocellular carcinoma cells. 117
Human RCAN3 gene expression and cell growth in endothelial cells. 111
Galloflavin prevents the binding of lactate dehydrogenase A to single stranded DNA and inhibits RNA synthesis in cultured cells. 107
null 101
Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulationin Burkitt lymphoma cells via NAD/NADH-dependent inhibition of sirtuin-1 92
null 71
NAD metabolism and functions: a common therapeutic target for neoplastic, metabolic and neurodegenerative diseases 69
Identification of N-acylhydrazone derivatives as novel lactate dehydrogenase A inhibitors 47
Inhibition of lactate dehydrogenase activity as an approach to cancer therapy 31
Totale 1.288
Categoria #
all - tutte 2.901
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.901


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201936 0 0 0 0 0 0 0 0 0 0 20 16
2019/2020388 44 9 5 16 43 41 51 65 57 26 22 9
2020/2021135 42 5 12 17 1 2 0 7 26 5 6 12
2021/2022209 13 1 22 17 26 9 4 15 10 11 51 30
2022/2023326 26 56 5 51 23 27 6 23 56 8 15 30
2023/202485 2 16 5 16 2 33 3 3 2 3 0 0
Totale 1.288